Session Details
[S5]Symposium 5 Gene therapy cutting edge
Thu. Oct 10, 2024 12:55 PM - 2:55 PM JST
Thu. Oct 10, 2024 3:55 AM - 5:55 AM UTC
Thu. Oct 10, 2024 3:55 AM - 5:55 AM UTC
Room 3（Empress hall, 2F）
Chairs：Tojo Nakayama（Neurology and Neurological Science Tokyo Medical and Dental University）, Mariko Taniguchi-Ikeda（Fujita Health University Hospital）
[S5-1]Advancing N-of-1 Oligonucleotide Therapeutics in Japan: Establishing a Centralized Drug Discovery Model
○Tojo Nakayama1,2 (1.Neurology and Neurological Science, Tokyo Medical and Dental University, 2.Nucleotide and Peptide Drug Discovery Center, Tokyo Medical and Dental University)
[S5-2]Development of gene therapy for intellectual disabilities in Down syndrome using new genome editing technologies
○Yasuji Kitabatake (Department of Pediatrics, Osaka University Graduate School of Medicine)
[S5-3]Designable chimeric RNAs that induce exon skipping
○Shinichi Nakagawa (Faculty of Pharmaceutical Sciences, Hokkaido University, Japan)
[S5-4]Strategic technology solutions for manufacturing high-quality gene therapy vectors
○Takashi Okada (Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo)